Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2009 1
2011 2
2012 2
2013 1
2014 7
2015 8
2016 7
2017 8
2018 3
2019 5
2020 5
2021 9
2022 15
2023 22
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Transrectal prostate biopsy: easy, effective and safe.
Diamand R, Peltier A, Albisinni S. Diamand R, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2024 Apr 16. doi: 10.1038/s41391-024-00823-1. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38627538 No abstract available.
Penile rehabilitation after pelvic cancer surgery.
Aoun F, Peltier A, van Velthoven R. Aoun F, et al. Among authors: peltier a. ScientificWorldJournal. 2015;2015:876046. doi: 10.1155/2015/876046. Epub 2015 Feb 15. ScientificWorldJournal. 2015. PMID: 25785286 Free PMC article. Review.
Bladder cancer immunotherapy: swinging for the fences.
Aoun F, El Rassy E, Peltier A. Aoun F, et al. Among authors: peltier a. Future Oncol. 2017 Apr;13(9):773-775. doi: 10.2217/fon-2017-0013. Epub 2017 Feb 10. Future Oncol. 2017. PMID: 28183191 No abstract available.
MRI lesion size is more important than the number of positive biopsy cores in predicting adverse features and recurrence after radical prostatectomy: implications for active surveillance criteria in intermediate-risk patients.
Baboudjian M, Uleri A, Beauval JB, Touzani A, Diamand R, Roche JB, Lacetera V, Lechevallier E, Roumeguère T, Simone G, Benamran D, Fourcade A, Fiard G, Peltier A, Ploussard G. Baboudjian M, et al. Among authors: peltier a. Prostate Cancer Prostatic Dis. 2023 Jul 14. doi: 10.1038/s41391-023-00693-z. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 37452146
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort study.
Kwong JCC, Khondker A, Meng E, Taylor N, Kuk C, Perlis N, Kulkarni GS, Hamilton RJ, Fleshner NE, Finelli A, van der Kwast TH, Ali A, Jamal M, Papanikolaou F, Short T, Srigley JR, Colinet V, Peltier A, Diamand R, Lefebvre Y, Mandoorah Q, Sanchez-Salas R, Macek P, Cathelineau X, Eklund M, Johnson AEW, Feifer A, Zlotta AR. Kwong JCC, et al. Among authors: peltier a. Lancet Digit Health. 2023 Jul;5(7):e435-e445. doi: 10.1016/S2589-7500(23)00067-5. Epub 2023 May 19. Lancet Digit Health. 2023. PMID: 37211455 Free article.
Testicular microlithiasis: Systematic review and Clinical guidelines.
Aoun F, Slaoui A, Naoum E, Hassan T, Albisinni S, Azzo JM, Kallas-Chemaly A, Assenmacher G, Peltier A, Roumeguère T. Aoun F, et al. Among authors: peltier a. Prog Urol. 2019 Sep;29(10):465-473. doi: 10.1016/j.purol.2019.07.001. Epub 2019 Aug 2. Prog Urol. 2019. PMID: 31383508
82 results